Quarry LP Cytokinetics Inc Transaction History

Quarry LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$46.36 - $58.62 $101,992 - $128,964	-2,200 Reduced 73.33%	800 $37.6 Million
Q3 2024 Nov 14, 2024	BUY	$51.22 - $60.16 $51,220 - $60,160	1,000 Added 50.0%	3,000 $158 Million
Q2 2024 Aug 14, 2024	BUY	$47.86 - $75.05 $67,004 - $105,070	1,400 Added 233.33%	2,000 $108 Million
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $38,250 - $64,836	600 New	600 $42.1 Million

404

126M

3.7M

890K

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $2.81B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Quarry LP, based on Form 13F filings with the SEC.

Stay updated on Quarry LP with notifications on news.